Resultados de la búsqueda 121-130 of 14594 for Paget's+disease

  1. Untitled

    Page 1.

  2. Untitled

    Page 1.

  3. Untitled

    Page 1.

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients with ALK aberrant tumors (ALK tyrosine kinase mutation or ALK amplification) will be non-randomly assigned to receive crizotinib added to current COG ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients with ALK aberrant tumors (ALK tyrosine kinase mutation or ALK amplification) will be non-randomly assigned to receive crizotinib added to current COG ...

  6. Mayo Clinic Neurosciences Physician Update — July 2024

    Page 1.

  7. Untitled

    Page 1.

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Patients with ALK aberrant tumors (ALK tyrosine kinase mutation or ALK amplification) will be non-randomly assigned to receive crizotinib added to current COG ...

  9. Untitled

    Page 1.

  10. Untitled

    Page 1.